Login
Life sciences company advised on merger
National law firm Piper Alderman has advised Brandwood CKC on its merger with PharmaLex Group, establishing an Australian presence.
Natasha Taylor
Firms: Piper Alderman (Brandwood CKC).
Value: Undisclosed.
Area: M&A.
Key players: The Piper Alderman team was led by partner Lis Boyce and associate Bahar Agar. The team assisted the board and shareholders of Brandwood CKC with negotiating and implementing the transaction documents and planning for post-completion operations.
Also providing support were partner Tim Capelin, who advised on employment aspects of the deal, and senior associate Samantha Gou, who advised on leasing negotiations.
Deal significance: According to Brandwood CKC’s statement, the merger allows Brandwood CKC to expand the range and geographical reach of services they can provide to their clients and support PharmaLex by providing global expertise in the medical device and diagnostic sectors.
“Having worked with Brandwood CKC for a number of years, including the 2019 merger, it is very gratifying to have supported the team through this next important stage of growth and exciting to see the strategic potential for both organisations in the combination with Pharmalex,” said Ms Boyce.
“The opportunity the merger provides to our clients and international markets is a huge value add, and the support provided by Piper Alterman was invaluable to ensuring the transaction ran seamlessly,” said Brandwood CKC managing director Grant Bennett.
“We have always provided solid experience-backed support to clients, including access into Europe and the USA. However, having the support and access of PharmaLex in these regions takes us to the next level.”
